Notice of extraordinary general meeting of Genovis AB

Genovis AB (publ) shareholders are hereby called to an extraordinary general meeting on Wednesday, December 17, 2008, at 5:00 PM in the Enoch Thulin Room of the Betahuset building at IDEON in Lund, Sweden. The street address is Scheelevägen 17.

Registration
To participate in the meeting, shareholders must:
- Be entered in the share register kept by VPC AB by Wednesday, December 11, 2008.
AND
- Register with the company by 12:00 PM on Wednesday, December 11, 2008, by mail at IDEON, SE-223 70, Lund, Sweden; by fax at +46-46-12 80 20; by email at info@genovis.com; or by phone at +46-46-10 12 38. Please provide your name, personal/corporate ID number, and registered share holdings.
Shareholders who have nominee-registered shares must temporarily register the shares in their own names through their agents before December 11, 2008, in order to participate in the meeting.

Proposed agenda
1. Opening of the meeting.
2. Election of meeting chairperson.
3. Preparation and approval of voting list.
4. Approval of agenda.
5. Election of one or two persons to verify the minutes.
6. Confirmation that the meeting was duly convened.
7. Approval of the board’s proposed new share issue of up to 3 628 744 shares, each with a par value of SEK 0.40 with preemptive rights for current shareholders at a price of SEK 3 per share. The proceeds of the issue will be used to carry out the business development plan of the company and to further develop intangible values within medical imaging and delivery.
8. Authorization for the board to decide upon a new share issue
The Board propose that the shareholders' meeting decide upon authorization for the board to, up until the next annual general meeting, at one or more occasions, decide upon a new share issue, with or without preemptive rights for current shareholders. By a decision on a new share issue with support of the authorization the share capital will at the most rises by 2 177 246 SEK by issuing new shares at market price, yet in all maximum 5 443 116 shares at full subscription.
9. Closing of the meeting.

Meeting-related documents
The complete proposal as per item 7 and 8 above will be available at the company’s office at Scheelevägen 22, Box 790, 220 07 Lund, Sweden, and on the company web site at www.genovis.com from December 3, 2008, and will be sent to shareholders on request after providing us with their mailing address.

Lund, Sweden
November, 2008
The board of Genovis AB (publ)